The lungs in Alström syndrome: a retrospective analysis
Abstract
Background: Alström syndrome (AS) is a rare multisystemic disorder frequently associated with respiratory complications, which are a major cause of premature death. While fibrosis in multiple organs has been historically suggested as a hallmark of AS, including the lungs, definitive evidence in adult patients remains limited. Methods: We conducted a retrospective study of adult patients diagnosed as AS seen in our National Multidisciplianry AS clinic from 2010 to 2024. Lung function test and high-resolution computed tomography (HRCT) of the thorax was performed in a subset of patients. Postmortem lung tissue analysis was available from four patients. Findings: A total of 25/41 (61%) of the patients were unable to complete full lung function testing. Among those who did, 67% exhibited reduced lung volumes, with 47% showing decreased diffusing capacity of the lung for carbon monoxide but normal or elevated transfer coefficient for carbon monoxide, indicating extrapulmonary restrictive physiology. HRCT scans in 39 patients showed no evidence of diffuse interstitial lung fibrosis; however, breathing artefacts were common. Historical infantile cardiomyopathy was identified as a risk factor for adult pulmonary dysfunction. Post-mortem pathology reports were obtained from four patients and no diffuse fibrosis in the lung tissue was identified in any of the patients. Pulmonary hypertension and Acute Respiratory Distress Syndrome were identified as potential causes of respiratory morbidity and mortality, despite the absence of intrinsic interstitial lung disease. Interpretation: This is the first large cohort study to depict the lung in adult patients with AS. This study provides no evidence for diffuse interstitial lung fibrosis in adult patients with AS, challenging prior assumptions. Pulmonary dysfunction appears mainly due to extrapulmonary restrictive physiology, with infantile cardiomyopathy as a possible risk factor. Pulmonary hypertension and acute respiratory distress syndrome, rather than intrinsic lung disease, likely underlie respiratory morbidity and mortality, highlighting the need for focused cardiopulmonary care. Although this study represents one of the largest single-centre cohorts of patients with AS reported to date, the overall sample size remains limited due to the ultra-rare nature of the disease and findings should be interpreted with caution. Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Related
- Unexpected detrimental role of plasmacytoid dendritic cells during viral infections of the lungs
- Moderate exercise early after influenza virus infection reduces the Th1 inflammatory response in lungs of mice
- Popcorn-like nodules in the lungs of a patient with Sjögren's disease.
- Don't forget to safeguard the lungs during DCD multi-organ retrieval! Early in situ oxygenated preservation matters.
- Reply to Don't forget to safeguard the lungs during DCD multi-organ retrieval! Early in situ oxygenated preservation matters.
BibTeX
@article{madathil2026lungs,
title = {{The lungs in Alström syndrome: a retrospective analysis}},
author = {Shyam C. Madathil and Qianwen Zhang and Tarekegn Geberhiwot},
journal = {eClinicalMedicine},
year = {2026},
month = oct,
doi = {10.1016/j.eclinm.2026.104292},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2589537026005456},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - The lungs in Alström syndrome: a retrospective analysis
AU - Shyam C. Madathil
AU - Qianwen Zhang
AU - Tarekegn Geberhiwot
PY - 2026
DA - 2026/10/24
JO - eClinicalMedicine
DO - 10.1016/j.eclinm.2026.104292
UR - https://linkinghub.elsevier.com/retrieve/pii/S2589537026005456
AB - Background: Alström syndrome (AS) is a rare multisystemic disorder frequently associated with respiratory complications, which are a major cause of premature death. While fibrosis in multiple organs has been historically suggested as a hallmark of AS, including the lungs, definitive evidence in adult patients remains limited. Methods: We conducted a retrospective study of adult patients diagnosed as AS seen in our National Multidisciplianry AS clinic from 2010 to 2024. Lung function test and high-resolution computed tomography (HRCT) of the thorax was performed in a subset of patients. Postmortem lung tissue analysis was available from four patients. Findings: A total of 25/41 (61%) of the patients were unable to complete full lung function testing. Among those who did, 67% exhibited reduced lung volumes, with 47% showing decreased diffusing capacity of the lung for carbon monoxide but normal or elevated transfer coefficient for carbon monoxide, indicating extrapulmonary restrictive physiology. HRCT scans in 39 patients showed no evidence of diffuse interstitial lung fibrosis; however, breathing artefacts were common. Historical infantile cardiomyopathy was identified as a risk factor for adult pulmonary dysfunction. Post-mortem pathology reports were obtained from four patients and no diffuse fibrosis in the lung tissue was identified in any of the patients. Pulmonary hypertension and Acute Respiratory Distress Syndrome were identified as potential causes of respiratory morbidity and mortality, despite the absence of intrinsic interstitial lung disease. Interpretation: This is the first large cohort study to depict the lung in adult patients with AS. This study provides no evidence for diffuse interstitial lung fibrosis in adult patients with AS, challenging prior assumptions. Pulmonary dysfunction appears mainly due to extrapulmonary restrictive physiology, with infantile cardiomyopathy as a possible risk factor. Pulmonary hypertension and acute respiratory distress syndrome, rather than intrinsic lung disease, likely underlie respiratory morbidity and mortality, highlighting the need for focused cardiopulmonary care. Although this study represents one of the largest single-centre cohorts of patients with AS reported to date, the overall sample size remains limited due to the ultra-rare nature of the disease and findings should be interpreted with caution. Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
SN - 2589-5370
ER -